Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Photo by News Øresund – Johan Wessman via CC BY 2.0

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read

June 2, 2025, New York, United States: A Wall Street road sign is seen in the Financial District in Manhattan, New York City. (Credit Image: © Jimin Kim/SOPA Images via ZUMA Press Wire) (Newscom TagID: zumaglobalsixteen137558.jpg) [Photo via Newscom]

Banking

Goldman Sachs Taps a New Generation of Leadership Ahead of Deals Boom

The toast of Wall Street has elevated a new generation of executives to run its investment banking and trading operations.

2 min read
Photo via Connor Lin / The Daily Upside

Artificial Intelligence

Mistral CEO Says the Company Wants an IPO

Mistral is among a clutch of privately held AI startups like OpenAI and Anthropic that have seen valuations soar.

1 min read
Photo by Kostas Dimopoulos via Pexels

Policy & Power

Is Trump Pivoting From a Trade War to an International Tax Fight?

The Trump 2.0 era may have officially begun this week, but the much-hyped tariff-fueled trade war has not. At least, not yet.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.